Daiichi Sankyo Co Ltd (4568.T)

4568.T on Tokyo Stock Exchange

1,924JPY
27 Mar 2015
Change (% chg)

¥-60 (-3.05%)
Prev Close
¥1,984
Open
¥1,934
Day's High
¥1,970
Day's Low
¥1,908
Volume
3,650,300
Avg. Vol
3,830,865
52-wk High
¥2,035
52-wk Low
¥1,556

4568.T

Chart for 4568.T

About

DAIICHI SANKYO COMPANY, LIMITED is a Japan-based holding company mainly engaged in the manufacture and sale of pharmaceuticals. The Company has two business segments. The Daiichi Sankyo Group segment is involved in the research, development, manufacture and sale of pharmaceuticals, as well as the provision of intermediates and... (more)

Overall

Beta: 0.69
Market Cap(Mil.): ¥1,364,138.00
Shares Outstanding(Mil.): 709.01
Dividend: 30.00
Yield (%): 3.12

Financials

  4568.T Industry Sector
P/E (TTM): 15.37 40.31 40.78
EPS (TTM): 125.14 -- --
ROI: 5.91 16.86 16.19
ROE: 8.52 17.40 17.04
Search Stocks

Daiichi Sankyo to pay $39 million to settle U.S. kickback claims: DOJ

- The U.S. subsidiary of global pharmaceutical company Daiichi Sankyo Co Ltd has agreed to pay $39 million to the U.S. government and state Medicaid programs to settle claims it paid doctors kickbacks to prescribe its drugs, the Department of Justice said on Friday.

09 Jan 2015

CORRECTED-Daiichi Sankyo to pay $39 million to settle U.S. kickback claims -DOJ

Jan 9 - The U.S. subsidiary of global pharmaceutical company Daiichi Sankyo Co Ltd has agreed to pay $39 million to the U.S. government and state Medicaid programs to settle claims it paid doctors kickbacks to prescribe its drugs, the Department of Justice said on Friday.

09 Jan 2015

U.S. FDA approves Daiichi anti-clotting drug

- U.S. regulators on Thursday approved the use of a drug made by Daiichi Sankyo Co Ltd to reduce the risk of stroke and blood clots in patients with an irregular heartbeat not caused by a heart valve problem.

09 Jan 2015

BRIEF-UCB announces partnership with Daiichi Sankyo in Japan

* Announces partnership with Daiichi Sankyo for co-commercialization of Lacosamide in Japan

28 Nov 2014

FDA panel backs Daiichi's blood thinner

- A panel of advisers to the U.S. Food and Drug Administration voted 9-1 in favor of approving Japanese drugmaker Daiichi Sankyo Co's blood thinner for use in some patients with atrial fibrillation.

30 Oct 2014

UPDATE 1-FDA panel backs Daiichi's blood thinner

* If approved, will compete with three new-generation drugs (Adds details, background)

30 Oct 2014

FDA panel backs Daiichi's blood thinner

Oct 30 - A panel of advisers to the U.S. Food and Drug Administration voted 9-1 in favor of approving Japanese drugmaker Daiichi Sankyo Co's blood clot and stroke preventer for use in some patients with atrial fibrillation.

30 Oct 2014

FDA staff recommends limited use of Daiichi's blood thinner

- U.S. Food and Drug Administration staff reviewers recommended approval of a 60 mg dose of Daiichi Sankyo Co's blood thinner for some atrial fibrillation patients, but suggested limiting its use to those with abnormal kidney function.

28 Oct 2014

UPDATE 1-FDA staff recommends limited use of Daiichi's blood thinner

Oct 28 - U.S. Food and Drug Administration staff reviewers recommended approval of a 60 mg dose of Daiichi Sankyo Co's blood thinner for some atrial fibrillation patients, but suggested limiting its use to those with abnormal kidney function.

28 Oct 2014

FDA staff recommends limited use of Daiichi's blood thinner

Oct 28 - U.S. Food and Drug Administration staff reviewers recommended approval of a 60 mg dose of Daiichi Sankyo Co's blood thinner for certain atrial fibrillation patients, but suggested limiting its use in those with abnormal kidney function.

28 Oct 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Reuters Investment Profile
£10.00
Provider: GlobalData
£81.00
Provider: GlobalData
£81.00
Provider: MarketLine (a Datamonitor Company)
£114.00
Provider: GlobalData
£81.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks